Principal Scientist Antibody Cell Line Development United States
alnylam
About this role
Alnylam is seeking a Principal Scientist to lead cell line and upstream process development for monoclonal antibodies and antibody-oligo conjugates. The position involves overseeing activities at CDMOs, ensuring smooth transition from discovery to manufacturing, and working across research and CMC functions to advance therapeutic molecules.
Skills
Qualifications
About alnylam
alnylam.comNew Relic is a SaaS observability and telemetry platform that helps engineering teams instrument, monitor, and troubleshoot applications and cloud infrastructure. It ingests metrics, events, logs, traces, and browser real-user data to deliver APM, distributed tracing, infrastructure monitoring, log management, synthetics, and RUM. The platform provides unified dashboards, alerting, anomaly detection, and root-cause analysis, plus integrations with cloud providers, services, and CI/CD tooling. Teams use New Relic to improve performance, accelerate incident response, and gain end-to-end visibility into customer experience and system health.
About alnylam
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for alnylam.
Salary
$147k – $221k
per year
More jobs at alnylam
Similar Jobs
Research (or Senior) Scientist - Antibody Discovery & Optimization
City of Pierre, South Dakota
Scientist -Antibody Technologies – Required Flow Cytometry, Tissue Culture & lab Exp)
gomillenniumsoft
Senior Scientist, Gene Therapy Potency – CMC Analytical Development
Neurocrine Biosciences
Associate Principal Scientist, Antibody Discovery Innovation
MSD
Associate Principal Scientist, Antibody Discovery Innovation
MSD
Senior Principal Scientist | Antibody-siRNA Bioanalytical & Biodistribution Strategy Lead
Amgen